On the minds of every employer today is the cost of specialty drugs, however as industry focus shifts, generic drugs are seeing a dramatic rise in costs. Turing pharmaceuticals and the Daraprim fiasco brought to light a much larger problem. Martin Shkreli leveraged the ongoing trend of purchasing off-patent drugs...
Read more
As we brace for healthcare changes in the coming years, one particular trend that will negatively impact consumer out-of-pocket costs is the use of co-insurance (instead of a co-pay) for expensive specialty medications. Many consumers are accustomed to paying flat insurance co-pay amounts for various tiers of medications, with...
Read more
A new CVS Caremark report projects that specialty drug spend is expected to quadruple in 2020, reaching approximately $418 billion a year. Currently, specialty drug spend accounts for 30% of the total drug spend and by 2018, it will account for half of a companies drug spend. This article...
Read more
2019, TESSER HEALTH, AN ELMC MEMBER COMPANY